organization · Reporting owner

InterWest Management Partners X, LLC

Disclosed activity across 6 companies

Tapewire entity: 130684
SEC CIK: 0001460207

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Braze, Inc.BRZE · Entity 4102	10% owner	February 08, 2022	February 09, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Braze, Inc.

Report date February 08, 2022 · Filed February 09, 2022

Jointly reported with INTERWEST PARTNERS X LP, Kliman Gilbert H, NASR KHALED, Desai Keval

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectBy: InterWest Partners X, LP	3,394,219	Reported balance After 2022-02-08 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2022-02-08 · Conversion · Acquired 3,394,219 · Balance 3,394,219 F1: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F2: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein.
Class B Common StockSEC Table II · derivative / convertible security	IndirectBy: InterWest Partners X, LP	0	Reported balance After 2022-02-08 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-02-08 · Conversion · Disposed 3,394,219 · Balance 0 F1: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F3: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F2: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder.

F2: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein.

F3: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock.

Past disclosures · reporting ended (5)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

AVEDRO INC

Report date November 21, 2019 · Filed November 25, 2019

Jointly reported with INTERWEST PARTNERS X LP, ORONSKY ARNOLD L, NASR KHALED, Desai Keval, Kliman Gilbert H

Section 16 reporting ended · disclosed 2019-11-25. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2019-11-21 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2019-11-21 · Other · Disposed 2,742,239 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated as of August 7, 2019, by and among Avedro, Inc. (the "Issuer"), Glaukos Corporation ("Parent") and Atlantic Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), on November 21, 2019, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer continuing as the surviving corporation. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock of the Issuer ("Issuer Common Stock") that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive 0.365 of a share of Parent's common stock ("Parent Common Stock"). The closing price of shares of the Parent Common Stock on November 21, 2019 was $63.07 per share. F2: The securities are directly held by InterWest Partners X, LP ("IW10"). InterWest Management Partners X, LLC ("IMP10"), as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. Arnold L. Oronsky and Gilbert H. Kliman are Managing Directors of IMP10, and Khaled A. Nasr and Keal Desai are Venture Members of IMP10. Each of the foregoing persons may be deemed to beneficially own the shares held by IW10, and each foregoing person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnote	0	Reported balance After 2019-11-21 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2019-11-21 · Other · Disposed 3,005 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated as of August 7, 2019, by and among Avedro, Inc. (the "Issuer"), Glaukos Corporation ("Parent") and Atlantic Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), on November 21, 2019, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer continuing as the surviving corporation. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock of the Issuer ("Issuer Common Stock") that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive 0.365 of a share of Parent's common stock ("Parent Common Stock"). The closing price of shares of the Parent Common Stock on November 21, 2019 was $63.07 per share. F3: The securities are directly held by InterWest Venture Management Company ("IVMC"). Gilbert H. Kliman transferred these shares to IVMC for no consideration pursuant to a contractual agreement between Kliman and IW10. Arnold L. Oronsky and Gilbert H. Kliman are owners, directors and officers of IVMC and as such may be deemed to beneficially own the shares held by IVMC. Each of Arnold L. Oronsky and Gilbert H. Kliman disclaim beneficial ownership of such shares except to the extend of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated as of August 7, 2019, by and among Avedro, Inc. (the "Issuer"), Glaukos Corporation ("Parent") and Atlantic Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), on November 21, 2019, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer continuing as the surviving corporation. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock of the Issuer ("Issuer Common Stock") that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive 0.365 of a share of Parent's common stock ("Parent Common Stock"). The closing price of shares of the Parent Common Stock on November 21, 2019 was $63.07 per share.

F2: The securities are directly held by InterWest Partners X, LP ("IW10"). InterWest Management Partners X, LLC ("IMP10"), as the general partner of IW10, may be deemed to beneficially own the shares held by IW10. Arnold L. Oronsky and Gilbert H. Kliman are Managing Directors of IMP10, and Khaled A. Nasr and Keal Desai are Venture Members of IMP10. Each of the foregoing persons may be deemed to beneficially own the shares held by IW10, and each foregoing person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

F3: The securities are directly held by InterWest Venture Management Company ("IVMC"). Gilbert H. Kliman transferred these shares to IVMC for no consideration pursuant to a contractual agreement between Kliman and IW10. Arnold L. Oronsky and Gilbert H. Kliman are owners, directors and officers of IVMC and as such may be deemed to beneficially own the shares held by IVMC. Each of Arnold L. Oronsky and Gilbert H. Kliman disclaim beneficial ownership of such shares except to the extend of his pecuniary interest therein.

Doximity, Inc.

Report date December 02, 2021 · Filed December 06, 2021

Jointly reported with INTERWEST PARTNERS X LP, NASR KHALED, Desai Keval

Section 16 reporting ended · disclosed 2021-12-06. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	4,300,000	Reported balance After 2021-12-02 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2021-12-02 · Conversion · Acquired 4,300,000 · Balance 4,300,000 F1: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F4: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein.
Class A Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2021-12-02 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2021-12-02 · Other · Disposed 4,300,000 · Balance 0 F2: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 1,101,094 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner.
Class A Common StockSEC Table I · non-derivative	IndirectBy: InterWest Management Partners X, LLC	0	Last balance in matching sequence After 2021-12-02 transaction · row 4 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 3 · 2021-12-02 · Other · Acquired 1,101,094 · Balance 1,101,094 F2: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 1,101,094 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F4: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein. Row 4 · 2021-12-02 · Other · Disposed 1,101,094 · Balance 0 F3: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 41,070 shares distributed to Khaled A. Nasr ("Nasr"), 27,527 shares distributed to Keval Desai ("Desai") and 249,778 shares distributed to Gilbert H. Kliman ("Kliman"), as reported on Kliman's separate Form 4 in his own name. F4: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein.
Class A Common StockSEC Table I · non-derivative	IndirectBy: Khaled A. Nasr	81,696	Reported balance After 2021-12-02 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 5 · 2021-12-02 · Other · Acquired 41,070 · Balance 81,696 F3: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 41,070 shares distributed to Khaled A. Nasr ("Nasr"), 27,527 shares distributed to Keval Desai ("Desai") and 249,778 shares distributed to Gilbert H. Kliman ("Kliman"), as reported on Kliman's separate Form 4 in his own name. F4: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein.
Class A Common StockSEC Table I · non-derivative	IndirectBy: Keval Desai	54,756	Reported balance After 2021-12-02 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 6 · 2021-12-02 · Other · Acquired 27,527 · Balance 54,756 F3: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 41,070 shares distributed to Khaled A. Nasr ("Nasr"), 27,527 shares distributed to Keval Desai ("Desai") and 249,778 shares distributed to Gilbert H. Kliman ("Kliman"), as reported on Kliman's separate Form 4 in his own name. F4: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein.
Class B Common StockSEC Table II · derivative / convertible security	Direct	8,556,998	Reported balance After 2021-12-02 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2021-12-02 · Conversion · Disposed 4,300,000 · Balance 8,556,998 F5: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F1: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F4: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F2: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 1,101,094 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner.

F3: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 41,070 shares distributed to Khaled A. Nasr ("Nasr"), 27,527 shares distributed to Keval Desai ("Desai") and 249,778 shares distributed to Gilbert H. Kliman ("Kliman"), as reported on Kliman's separate Form 4 in his own name.

F4: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein.

F5: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class.

Eiger BioPharmaceuticals, Inc.

Report date October 18, 2018 · Filed October 22, 2018

Jointly reported with INTERWEST PARTNERS X LP, Kliman Gilbert H, ORONSKY ARNOLD L, Desai Keval, NASR KHALED

Section 16 reporting ended · disclosed 2018-10-22. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,362,327	Last balance in matching sequence After 2018-10-18 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2018-10-18 · Sale · Disposed 210,800 · Balance 1,388,792 F1: Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $12.00 to $12.30 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3: These securities are held of record by InterWest Partners X, L.P. ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10. Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, are Venture Members of IMP10. All Reporting Persons disclaim beneficial ownership of shares of Eiger BioPharmaceuticals, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement. Row 2 · 2018-10-18 · Sale · Disposed 26,465 · Balance 1,362,327 F2: Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $12.00 to $12.03 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3: These securities are held of record by InterWest Partners X, L.P. ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10. Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, are Venture Members of IMP10. All Reporting Persons disclaim beneficial ownership of shares of Eiger BioPharmaceuticals, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement.

Filing footnotes · ownership attribution and instrument terms

F1: Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $12.00 to $12.30 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2: Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $12.00 to $12.03 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3: These securities are held of record by InterWest Partners X, L.P. ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10. Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, are Venture Members of IMP10. All Reporting Persons disclaim beneficial ownership of shares of Eiger BioPharmaceuticals, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement.

PMV Pharmaceuticals, Inc.

Report date July 13, 2021 · Filed July 14, 2021

Jointly reported with INTERWEST PARTNERS X LP, NASR KHALED, Desai Keval, Kliman Gilbert H

Section 16 reporting ended · disclosed 2021-07-14. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	4,469,911	Reported balance After 2021-07-13 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2021-07-13 · Other · Disposed 500,000 · Balance 4,469,911 F1: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 97,632 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner.
Common StockSEC Table I · non-derivative	IndirectBy: InterWest Management Partners X, LLC	0	Last balance in matching sequence After 2021-07-13 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 2 · 2021-07-13 · Other · Acquired 97,632 · Balance 97,632 F1: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 97,632 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F3: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Row 3 · 2021-07-13 · Other · Disposed 97,632 · Balance 0 F2: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.
Common StockSEC Table I · non-derivative	IndirectBy: Khaled A. Nasr	4,201	Reported balance After 2021-07-13 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2021-07-13 · Other · Acquired 3,642 · Balance 4,201 F2: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.
Common StockSEC Table I · non-derivative	IndirectBy: Keval Desai	2,816	Reported balance After 2021-07-13 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 5 · 2021-07-13 · Other · Acquired 2,441 · Balance 2,816 F2: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.
Common StockSEC Table I · non-derivative	IndirectBy Gilbert H. Kliman	25,552	Reported balance After 2021-07-13 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 6 · 2021-07-13 · Other · Acquired 22,148 · Balance 25,552 F2: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.

Filing footnotes · ownership attribution and instrument terms

F1: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 97,632 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner.

F2: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman").

F3: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein.

Vyome Holdings, Inc

Report date August 06, 2019 · Filed August 08, 2019

Jointly reported with INTERWEST PARTNERS X LP, Kliman Gilbert H, ORONSKY ARNOLD L, Desai Keval, NASR KHALED

Section 16 reporting ended · disclosed 2019-08-08. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	380,224	Reported balance After 2019-08-06 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2019-08-06 · Purchase · Acquired 25,000 · Balance 380,224 F1: The reporting persons purchased these shares directly from the underwriter in the Issuer's registered offering of Common Stock with 75% warrant coverage at a price of $4.00 per unit. There was no additional consideration paid for the warrants. F2: These securities are held of record by InterWest Partners X, L.P. ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10. Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, and are Venture Members of IMP10. Douglas Fisher, a Member of IMP10 is also a Director of the Issuer, and when required, files a separate Form 4 in his own name. All Reporting Persons disclaim beneficial ownership of shares of Obalon Therapeutics, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement.
Warrants (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.40 · Expires 2024-08-05	Direct	18,750	Reported balance After 2019-08-06 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2019-08-06 · Purchase · Acquired 18,750 · Balance 18,750 F1: The reporting persons purchased these shares directly from the underwriter in the Issuer's registered offering of Common Stock with 75% warrant coverage at a price of $4.00 per unit. There was no additional consideration paid for the warrants. F2: These securities are held of record by InterWest Partners X, L.P. ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10. Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, and are Venture Members of IMP10. Douglas Fisher, a Member of IMP10 is also a Director of the Issuer, and when required, files a separate Form 4 in his own name. All Reporting Persons disclaim beneficial ownership of shares of Obalon Therapeutics, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement.

Filing footnotes · ownership attribution and instrument terms

F1: The reporting persons purchased these shares directly from the underwriter in the Issuer's registered offering of Common Stock with 75% warrant coverage at a price of $4.00 per unit. There was no additional consideration paid for the warrants.

F2: These securities are held of record by InterWest Partners X, L.P. ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10 and has sole voting and investment control over the shares owned by IW10. Gilbert H. Kliman, and Arnold L. Oronsky are Managing Directors of IMP10 and, Keval Desai and Khaled A. Nasr, and are Venture Members of IMP10. Douglas Fisher, a Member of IMP10 is also a Director of the Issuer, and when required, files a separate Form 4 in his own name. All Reporting Persons disclaim beneficial ownership of shares of Obalon Therapeutics, Inc. stock held by IW10, except to the extent of their respective pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1944, or otherwise, any of the Reporting Persons are the beneficial owner of all of the equity securities covered by this statement.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
February 08, 2022 Filed Feb 9, 2022 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionClass B Common Stock · Derivative	3,394,219	$0.00	$0.00	Disclosure SEC source: 0000899243-22-005442 · doc4.xml · derivative · entry 2 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Partners X, LP Disclosed balance after: 0 Underlying: Class A Common Stock · 3,394,219 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F3 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F3 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
February 08, 2022 Filed Feb 9, 2022 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionClass A Common Stock	3,394,219	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-22-005442 · doc4.xml · nonDerivative · entry 1 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Partners X, LP Disclosed balance after: 3,394,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F1 · price: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
December 02, 2021 Filed Dec 6, 2021 20:00 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionClass B Common Stock · Derivative	4,300,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-047009 · doc4.xml · derivative · entry 7 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,556,998 Underlying: Class A Common Stock · 4,300,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F5 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F5 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F4 · ownership.direct: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein. Read SEC document
December 02, 2021 Filed Dec 6, 2021 20:00 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	27,527	$0.00	$0.00	Disclosure SEC source: 0000899243-21-047009 · doc4.xml · nonDerivative · entry 6 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: Keval Desai Disclosed balance after: 54,756 F3 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 41,070 shares distributed to Khaled A. Nasr ("Nasr"), 27,527 shares distributed to Keval Desai ("Desai") and 249,778 shares distributed to Gilbert H. Kliman ("Kliman"), as reported on Kliman's separate Form 4 in his own name. F4 · ownership.nature: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein. Read SEC document
December 02, 2021 Filed Dec 6, 2021 20:00 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	41,070	$0.00	$0.00	Disclosure SEC source: 0000899243-21-047009 · doc4.xml · nonDerivative · entry 5 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: Khaled A. Nasr Disclosed balance after: 81,696 F3 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 41,070 shares distributed to Khaled A. Nasr ("Nasr"), 27,527 shares distributed to Keval Desai ("Desai") and 249,778 shares distributed to Gilbert H. Kliman ("Kliman"), as reported on Kliman's separate Form 4 in his own name. F4 · ownership.nature: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein. Read SEC document
December 02, 2021 Filed Dec 6, 2021 20:00 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	1,101,094	$0.00	$0.00	Disclosure SEC source: 0000899243-21-047009 · doc4.xml · nonDerivative · entry 4 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 0 F3 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 41,070 shares distributed to Khaled A. Nasr ("Nasr"), 27,527 shares distributed to Keval Desai ("Desai") and 249,778 shares distributed to Gilbert H. Kliman ("Kliman"), as reported on Kliman's separate Form 4 in his own name. F4 · ownership.nature: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein. Read SEC document
December 02, 2021 Filed Dec 6, 2021 20:00 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	1,101,094	$0.00	$0.00	Disclosure SEC source: 0000899243-21-047009 · doc4.xml · nonDerivative · entry 3 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 1,101,094 F2 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 1,101,094 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F4 · ownership.nature: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein. Read SEC document
December 02, 2021 Filed Dec 6, 2021 20:00 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	4,300,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-047009 · doc4.xml · nonDerivative · entry 2 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 1,101,094 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. Read SEC document
December 02, 2021 Filed Dec 6, 2021 20:00 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionClass A Common Stock	4,300,000	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-047009 · doc4.xml · nonDerivative · entry 1 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,300,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F1 · price: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F4 · ownership.direct: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionClass B Common Stock · Derivative	1,130,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · derivative · entry 9 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 3,394,219 Underlying: Class A Common Stock · 1,130,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F4 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F4 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	OtherClass B Common Stock · Derivative	4,524,219	$0.00	$0.00	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · derivative · entry 8 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 4,524,219 Underlying: Class A Common Stock · 4,524,219 shares Expires not disclosed F4 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F3 · kind: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. F4 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F4 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionSeries D Preferred Stock · Derivative	95,976	$0.00	$0.00	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · derivative · entry 7 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 0 Underlying: Common Stock · 95,976 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionSeries C Preferred Stock · Derivative	1,603,848	$0.00	$0.00	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · derivative · entry 6 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 0 Underlying: Common Stock · 1,603,848 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionSeries B Preferred Stock · Derivative	2,824,395	$0.00	$0.00	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · derivative · entry 5 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 0 Underlying: Common Stock · 2,824,395 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	SaleClass A Common Stock	1,130,000	$61.42	$69,404,600.00	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · nonDerivative · entry 4 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 0 F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionClass A Common Stock	1,130,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · nonDerivative · entry 3 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 1,130,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock (A) at any time at the option of the Reporting Person or (B) automatically upon the occurrence of the following: (1) the transfer of such share of Class B Common Stock, except for certain transfers whereby the Reporting Person continues to hold sole voting and dispositive power with respect to each such share, (2) the death of a Class B common stockholder who is a natural person, (3) the last trading day of the fiscal quarter immediately following the fifth anniversary of the Issuer's initial public offering, (4) the date specified by affirmative vote of the holders of a majority of the outstanding shares of Class B common stock and (5) the last trading day of the fiscal quarter during which the then outstanding shares of Class B Common Stock first represent less than 10% of the aggregate number of shares of the then outstanding Class A Common Stock and Class B Common Stock. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	OtherCommon Stock	4,524,219	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · nonDerivative · entry 2 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 0 F3 · kind: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. F3 · price: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 19, 2021 Filed Nov 23, 2021 22:00 UTC	Braze, Inc. BRZE · Entity 4102	ConversionCommon Stock	4,524,219	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-066518 · doc4.xml · nonDerivative · entry 1 InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners X, L.P. Disclosed balance after: 4,524,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis prior to being reclassified into shares of Series B Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering. F2 · ownership.nature: The reported securities are owned directly by InterWest Partners X, L.P. ("IW X"). The general partner of IW X is InterWest Management Partners X, LLC ("IMP X") and may be deemed to beneficially own the shares held by IW X. Gilbert H. Kliman is the managing director of IMP X and Keval Desai and Khaled A. Nasr are venture members of IMP X. The managing director and venture members of IMP X share voting and investment control with respect to the securities held by IW X. Each of IMP X, Mr. Kliman, Mr. Desai and Mr. Nasr disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. Read SEC document
November 12, 2021 Filed Nov 15, 2021 16:37 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionClass B Common Stock · Derivative	4,300,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-044589 · doc4.xml · derivative · entry 7 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,856,998 Underlying: Class A Common Stock · 4,300,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F5 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F5 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F4 · ownership.direct: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein. Read SEC document
November 12, 2021 Filed Nov 15, 2021 16:37 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	27,229	$0.00	$0.00	Disclosure SEC source: 0000899243-21-044589 · doc4.xml · nonDerivative · entry 6 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: Keval Desai Disclosed balance after: 27,229 F3 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 40,626 shares distributed to Khaled A. Nasr ("Nasr"), 27,229 shares distributed to Keval Desai ("Desai") and 247,074 shares distributed to Gilbert H. Kliman ("Kliman"), as reported on Kliman's separate Form 4 in his own name. F4 · ownership.nature: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein. Read SEC document
November 12, 2021 Filed Nov 15, 2021 16:37 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	40,626	$0.00	$0.00	Disclosure SEC source: 0000899243-21-044589 · doc4.xml · nonDerivative · entry 5 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: Khaled A. Nasr Disclosed balance after: 40,626 F3 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 40,626 shares distributed to Khaled A. Nasr ("Nasr"), 27,229 shares distributed to Keval Desai ("Desai") and 247,074 shares distributed to Gilbert H. Kliman ("Kliman"), as reported on Kliman's separate Form 4 in his own name. F4 · ownership.nature: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein. Read SEC document
November 12, 2021 Filed Nov 15, 2021 16:37 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	1,089,179	$0.00	$0.00	Disclosure SEC source: 0000899243-21-044589 · doc4.xml · nonDerivative · entry 4 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 0 F3 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 40,626 shares distributed to Khaled A. Nasr ("Nasr"), 27,229 shares distributed to Keval Desai ("Desai") and 247,074 shares distributed to Gilbert H. Kliman ("Kliman"), as reported on Kliman's separate Form 4 in his own name. F4 · ownership.nature: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein. Read SEC document
November 12, 2021 Filed Nov 15, 2021 16:37 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	1,089,179	$0.00	$0.00	Disclosure SEC source: 0000899243-21-044589 · doc4.xml · nonDerivative · entry 3 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 1,089,179 F2 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 1,089,179 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F4 · ownership.nature: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein. Read SEC document
November 12, 2021 Filed Nov 15, 2021 16:37 UTC	Doximity, Inc. DOCS · Entity 1570	OtherClass A Common Stock	4,300,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-044589 · doc4.xml · nonDerivative · entry 2 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 1,089,179 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. Read SEC document
November 12, 2021 Filed Nov 15, 2021 16:37 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionClass A Common Stock	4,300,000	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-21-044589 · doc4.xml · nonDerivative · entry 1 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,300,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F1 · price: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F4 · ownership.direct: These shares are directly held by IW10. IMP10 is the general partner of IW10. Gilbert H. Kliman is the Managing Director of IMP10. Keval Desai and Khaled Nasr are Venture Members of IMP10. Each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by IW10, and each of IMP10, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of only the shares held by IW10, except to the extent of its or his pecuniary interest therein. Read SEC document
July 13, 2021 Filed Jul 14, 2021 20:05 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	22,148	$0.00	$0.00	Disclosure SEC source: 0000899243-21-028387 · doc4.xml · nonDerivative · entry 6 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Gilbert H. Kliman Disclosed balance after: 25,552 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
July 13, 2021 Filed Jul 14, 2021 20:05 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	2,441	$0.00	$0.00	Disclosure SEC source: 0000899243-21-028387 · doc4.xml · nonDerivative · entry 5 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: Keval Desai Disclosed balance after: 2,816 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
July 13, 2021 Filed Jul 14, 2021 20:05 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	3,642	$0.00	$0.00	Disclosure SEC source: 0000899243-21-028387 · doc4.xml · nonDerivative · entry 4 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: Khaled A. Nasr Disclosed balance after: 4,201 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
July 13, 2021 Filed Jul 14, 2021 20:05 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	97,632	$0.00	$0.00	Disclosure SEC source: 0000899243-21-028387 · doc4.xml · nonDerivative · entry 3 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 0 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 3,642 shares distributed to Khaled A. Nasr ("Nasr"), 2,441 shares distributed to Keval Desai ("Desai") and 22,148 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
July 13, 2021 Filed Jul 14, 2021 20:05 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	97,632	$0.00	$0.00	Disclosure SEC source: 0000899243-21-028387 · doc4.xml · nonDerivative · entry 2 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 97,632 F1 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 97,632 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
July 13, 2021 Filed Jul 14, 2021 20:05 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	500,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-028387 · doc4.xml · nonDerivative · entry 1 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,469,911 F1 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 97,632 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. Read SEC document
June 28, 2021 Filed Jun 28, 2021 18:18 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionClass B Common Stock · Derivative	4,289,250	$0.00	$0.00	Disclosure SEC source: 0001628280-21-013077 · wf-form4_162491868260852.xml · derivative · entry 7 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner Desai Keval · CIK 0001553019 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,156,998 Underlying: Class A Common Stock · 4,289,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F5 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F5 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F2 · ownership.direct: These shares are directly held by InterWest Partners X, L.P. ("InterWest"). InterWest Management Partners X, LLC ("IMP X") is the general partner of InterWest. Gilbert H. Kliman is the Managing Director of IMP X. Keval Desai and Khaled Nasr are Venture Members of IMP X. Each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by InterWest, and each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein. Read SEC document
June 28, 2021 Filed Jun 28, 2021 18:18 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionClass B Common Stock · Derivative	21,446,248	$0.00	$0.00	Disclosure SEC source: 0001628280-21-013077 · wf-form4_162491868260852.xml · derivative · entry 6 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner Desai Keval · CIK 0001553019 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,446,248 Underlying: Class A Common Stock · 21,446,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F4 · kind: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of Class B Common Stock on a one-for-one basis, immediately prior to the closing of the IPO. The shares of Preferred Stock have no expiration date. F5 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F5 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F2 · ownership.direct: These shares are directly held by InterWest Partners X, L.P. ("InterWest"). InterWest Management Partners X, LLC ("IMP X") is the general partner of InterWest. Gilbert H. Kliman is the Managing Director of IMP X. Keval Desai and Khaled Nasr are Venture Members of IMP X. Each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by InterWest, and each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein. Read SEC document
June 28, 2021 Filed Jun 28, 2021 18:18 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionSeries C Preferred Stock · Derivative	2,736,772	$0.00	$0.00	Disclosure SEC source: 0001628280-21-013077 · wf-form4_162491868260852.xml · derivative · entry 5 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner Desai Keval · CIK 0001553019 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 2,736,772 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of Class B Common Stock on a one-for-one basis, immediately prior to the closing of the IPO. The shares of Preferred Stock have no expiration date. F4 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of Class B Common Stock on a one-for-one basis, immediately prior to the closing of the IPO. The shares of Preferred Stock have no expiration date. F4 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of Class B Common Stock on a one-for-one basis, immediately prior to the closing of the IPO. The shares of Preferred Stock have no expiration date. F5 · derivative.underlying: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F2 · ownership.direct: These shares are directly held by InterWest Partners X, L.P. ("InterWest"). InterWest Management Partners X, LLC ("IMP X") is the general partner of InterWest. Gilbert H. Kliman is the Managing Director of IMP X. Keval Desai and Khaled Nasr are Venture Members of IMP X. Each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by InterWest, and each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein. Read SEC document
June 28, 2021 Filed Jun 28, 2021 18:18 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionSeries B Preferred Stock · Derivative	5,412,972	$0.00	$0.00	Disclosure SEC source: 0001628280-21-013077 · wf-form4_162491868260852.xml · derivative · entry 4 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner Desai Keval · CIK 0001553019 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 5,412,972 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of Class B Common Stock on a one-for-one basis, immediately prior to the closing of the IPO. The shares of Preferred Stock have no expiration date. F4 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of Class B Common Stock on a one-for-one basis, immediately prior to the closing of the IPO. The shares of Preferred Stock have no expiration date. F4 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of Class B Common Stock on a one-for-one basis, immediately prior to the closing of the IPO. The shares of Preferred Stock have no expiration date. F5 · derivative.underlying: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F2 · ownership.direct: These shares are directly held by InterWest Partners X, L.P. ("InterWest"). InterWest Management Partners X, LLC ("IMP X") is the general partner of InterWest. Gilbert H. Kliman is the Managing Director of IMP X. Keval Desai and Khaled Nasr are Venture Members of IMP X. Each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by InterWest, and each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein. Read SEC document
June 28, 2021 Filed Jun 28, 2021 18:18 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionSeries A Preferred Stock · Derivative	13,296,504	$0.00	$0.00	Disclosure SEC source: 0001628280-21-013077 · wf-form4_162491868260852.xml · derivative · entry 3 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner Desai Keval · CIK 0001553019 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 13,296,504 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of Class B Common Stock on a one-for-one basis, immediately prior to the closing of the IPO. The shares of Preferred Stock have no expiration date. F4 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of Class B Common Stock on a one-for-one basis, immediately prior to the closing of the IPO. The shares of Preferred Stock have no expiration date. F4 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of Class B Common Stock on a one-for-one basis, immediately prior to the closing of the IPO. The shares of Preferred Stock have no expiration date. F5 · derivative.underlying: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class. F2 · ownership.direct: These shares are directly held by InterWest Partners X, L.P. ("InterWest"). InterWest Management Partners X, LLC ("IMP X") is the general partner of InterWest. Gilbert H. Kliman is the Managing Director of IMP X. Keval Desai and Khaled Nasr are Venture Members of IMP X. Each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by InterWest, and each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein. Read SEC document
June 28, 2021 Filed Jun 28, 2021 18:18 UTC	Doximity, Inc. DOCS · Entity 1570	SaleClass A Common Stock	4,289,250	$24.57	$105,386,872.50	Disclosure SEC source: 0001628280-21-013077 · wf-form4_162491868260852.xml · nonDerivative · entry 2 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner Desai Keval · CIK 0001553019 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · kind: These shares were sold by InterWest in connection with the Issuer's initial public offering ("IPO") at a net price per share of $24.57 (after underwriting discounts and commissions). InterWest was a selling stockholder in the IPO. F2 · ownership.direct: These shares are directly held by InterWest Partners X, L.P. ("InterWest"). InterWest Management Partners X, LLC ("IMP X") is the general partner of InterWest. Gilbert H. Kliman is the Managing Director of IMP X. Keval Desai and Khaled Nasr are Venture Members of IMP X. Each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by InterWest, and each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein. Read SEC document
June 28, 2021 Filed Jun 28, 2021 18:18 UTC	Doximity, Inc. DOCS · Entity 1570	ConversionClass A Common Stock	4,289,250	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-21-013077 · wf-form4_162491868260852.xml · nonDerivative · entry 1 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner Desai Keval · CIK 0001553019 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,289,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F1 · price: Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder. F2 · ownership.direct: These shares are directly held by InterWest Partners X, L.P. ("InterWest"). InterWest Management Partners X, LLC ("IMP X") is the general partner of InterWest. Gilbert H. Kliman is the Managing Director of IMP X. Keval Desai and Khaled Nasr are Venture Members of IMP X. Each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by InterWest, and each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein. Read SEC document
May 10, 2021 Filed May 12, 2021 06:10 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	1,135	$0.00	$0.00	Disclosure SEC source: 0000899243-21-019183 · doc4.xml · nonDerivative · entry 6 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Gilbert H. Kliman Disclosed balance after: 3,404 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 186 shares distributed to Khaled A. Nasr ("Nasr"), 125 shares distributed to Keval Desai ("Desai") and 1,135 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
May 10, 2021 Filed May 12, 2021 06:10 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	125	$0.00	$0.00	Disclosure SEC source: 0000899243-21-019183 · doc4.xml · nonDerivative · entry 5 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: Keval Desai Disclosed balance after: 375 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 186 shares distributed to Khaled A. Nasr ("Nasr"), 125 shares distributed to Keval Desai ("Desai") and 1,135 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
May 10, 2021 Filed May 12, 2021 06:10 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	186	$0.00	$0.00	Disclosure SEC source: 0000899243-21-019183 · doc4.xml · nonDerivative · entry 4 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: Khaled A. Nasr Disclosed balance after: 559 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 186 shares distributed to Khaled A. Nasr ("Nasr"), 125 shares distributed to Keval Desai ("Desai") and 1,135 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
May 10, 2021 Filed May 12, 2021 06:10 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	5,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-019183 · doc4.xml · nonDerivative · entry 3 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 0 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 186 shares distributed to Khaled A. Nasr ("Nasr"), 125 shares distributed to Keval Desai ("Desai") and 1,135 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
May 10, 2021 Filed May 12, 2021 06:10 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	5,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-019183 · doc4.xml · nonDerivative · entry 2 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 5,000 F1 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 5,000 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
May 10, 2021 Filed May 12, 2021 06:10 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	500,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-019183 · doc4.xml · nonDerivative · entry 1 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,969,911 F1 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 5,000 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. Read SEC document
March 24, 2021 Filed Mar 25, 2021 19:34 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	2,269	$0.00	$0.00	Disclosure SEC source: 0000899243-21-013532 · doc4.xml · nonDerivative · entry 6 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Gilbert H. Kliman Disclosed balance after: 2,269 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 373 shares distributed to Khaled A. Nasr ("Nasr"), 250 shares distributed to Keval Desai ("Desai") and 2,269 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
March 24, 2021 Filed Mar 25, 2021 19:34 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	250	$0.00	$0.00	Disclosure SEC source: 0000899243-21-013532 · doc4.xml · nonDerivative · entry 5 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: Keval Desai Disclosed balance after: 250 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 373 shares distributed to Khaled A. Nasr ("Nasr"), 250 shares distributed to Keval Desai ("Desai") and 2,269 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
March 24, 2021 Filed Mar 25, 2021 19:34 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	373	$0.00	$0.00	Disclosure SEC source: 0000899243-21-013532 · doc4.xml · nonDerivative · entry 4 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: Khaled A. Nasr Disclosed balance after: 373 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 373 shares distributed to Khaled A. Nasr ("Nasr"), 250 shares distributed to Keval Desai ("Desai") and 2,269 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
March 24, 2021 Filed Mar 25, 2021 19:34 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	10,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-013532 · doc4.xml · nonDerivative · entry 3 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 0 F2 · kind: Represents pro rata in-kind distribution by IMP10 without consideration to its members in accordance with the terms of the InterWest Management Partners X, LLC Operating Agreement. Includes 373 shares distributed to Khaled A. Nasr ("Nasr"), 250 shares distributed to Keval Desai ("Desai") and 2,269 shares distributed to Gilbert H. Kliman ("Kliman"). F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
March 24, 2021 Filed Mar 25, 2021 19:34 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	10,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-013532 · doc4.xml · nonDerivative · entry 2 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By: InterWest Management Partners X, LLC Disclosed balance after: 10,000 F1 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 10,000 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. F3 · ownership.nature: The shares are held directly by IW10. The general partner of IW10 is IMP10. Kliman is a Managing Director of IMP10 and Nasr and Desai are Venture Members of IMP10. Each of Nasr, Desai and Kliman share voting and investment control over the shares owned by IW10, and may be deemed to beneficially own the shares held by IW10. Each of Nasr, Desai and Kliman disclaims beneficial ownership of such shares except to the extent of his pecuniaryinterest theriein. Read SEC document
March 24, 2021 Filed Mar 25, 2021 19:34 UTC	PMV Pharmaceuticals, Inc. PMVP · Entity 7062	OtherCommon Stock	1,000,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-013532 · doc4.xml · nonDerivative · entry 1 INTERWEST PARTNERS X LP · CIK 0001443898 · 10% owner InterWest Management Partners X, LLC · CIK 0001460207 · 10% owner NASR KHALED · CIK 0001276600 · 10% owner Desai Keval · CIK 0001553019 · 10% owner Kliman Gilbert H · CIK 0001293171 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,469,911 F1 · kind: Represents pro rata in-kind distribution by InterWest Partners X, LP ("IW10") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners X, LP Limited Partnership Agreement. Includes 10,000 shares distributed to InterWest Management Partners X, LLC ("IMP10") its general partner. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.